Literature DB >> 923643

Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.

R E Heikkila, F S Cabbat, C Mytilineou.   

Abstract

The effects of the anorexic and stimulant agents mazindol and dita on 3H-biogenic amine uptake and release were determined. Mazindol and dita were very potent inhibitors of 3H-norepinephrine uptake into rat brain occipital cortex slices with ED50 values (point of 50% inhibition of uptake) of 1.5 X 10(-9) M and 3.2 X 10(-9) M, respectively. Mazindol (ED50 of 2.8 X 10(-7) M) and dita (ED50 value of 8.5 X 10(-7) M) were also potent inhibitors of 3H-dopamine uptake into rat neostriatal slices and of 3H-serotonin uptake into whole brain slices (ED50 values of 5.5 X 10(-7) M and 5.1 X 10(-7) M for mazindol and dita respectively). Both compounds proved however to be extremely weak releasing agents for the 3H-biogenic amines in the respective brain areas. The effects of mazindol and dita on uptake may help to explain some of their pharmacological properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923643     DOI: 10.1016/0014-2999(77)90271-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The anorectic action of mazindol.

Authors:  K F Sweeney
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

2.  Inhibition of potassium-stimulated release of [3H]dopamine from rat striata as a result of prior exposure to cocaine, nomifensine, or mazindol.

Authors:  D Dembiec
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

3.  Effect of mazindol on brain dopamine turnover in spiperone-treated rats.

Authors:  R W Fuller; H D Snoddy
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

4.  Influence of naloxone upon motor activity induced by psychomotor stimulant drugs.

Authors:  D N Jones; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.